Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,669,634
+$446,105 QoQ
Shares Held
69,337
+59.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,032
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL MCLEOD PUGH & WILLIAMS INC holds $30,637,991 across 10 Drug Manufacturers - General names. PFE ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,466 | $8,954,945 | |
| 2 | JNJ |
Johnson & Johnson
|
28,718 | $7,293,509 | |
| 3 | ABBV |
AbbVie Inc.
|
20,243 | $5,093,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,603 | $3,289,985 | |
| 5 | PFE |
Pfizer Inc
This page
|
69,337 | $1,669,634 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,456 | $1,121,054 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
8,716 | $1,101,179 | |
| 8 | AMGN |
Amgen Inc
|
2,634 | $953,824 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,669,634 | 69,337 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,223,529 | 43,573 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $957,131 | 38,439 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,065,853 | 41,831 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,025,739 | 42,316 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $873,140 | 34,457 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $878,832 | 33,126 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $949,289 | 32,802 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $913,267 | 32,640 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $904,761 | 32,604 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $957,584 | 33,261 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,162,873 | 35,058 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $1,285,340 | 35,042 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,429,591 | 35,039 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,791,145 | 34,956 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,486,877 | 33,978 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,769,827 | 33,756 | Shares | Sole | 2022-11-18 | |
| 2022-03-31 | $1,766,754 | 34,127 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,976,167 | 33,466 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,417,867 | 32,966 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,290,948 | 32,966 | Shares | Sole | 2021-11-08 | |
| 2021-03-31 | $1,165,120 | 32,159 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,143,870 | 31,075 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,141,038 | 31,091 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $955,037 | 29,206 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $561,505 | 17,203 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||